HomeNewsBusinessCoworking companies optimistic as India Inc. vaccinates staff for return to office
Trending Topics

Coworking companies optimistic as India Inc. vaccinates staff for return to office

Cost savings, leases expiring in three years and hybrid working trends will help accelerate growth in the flexible office space business

July 15, 2021 / 14:55 IST
Story continues below Advertisement
General view of a coworking office space (Photo by Austin Distel on Unsplash)
General view of a coworking office space (Photo by Austin Distel on Unsplash)

India Inc. is accelerating the vaccination of its employees, aiming to gradually bring them back to the office as the second COVID-19 wave tapers off. Coworking companies are unruffled and expect their offerings to become more attractive as the hybrid model of working becomes the new normal, boosting their growth by up to 15 percent.

Infosys, India’s second-largest information technology company, expects 20-30 percent of its workforce to be back in the office over the next six months.

Story continues below Advertisement

Rival Tata Consultancy Services said earlier this week it is hoping that its over 5 lakh employees return to the office by September, once they are vaccinated against the virus.

Recently, Flipkart said employees will return to office thrice a week from December 2021 as it looks to vaccinate all its staffers and move to a hybrid working model.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show